vTv Therapeutics Inc Class A (USD)
VTVT
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range2.75 | 2.89
52-Wk Range- | -
Last Close2.82
Mkt Cap (m)192.85
Dividend yield-
ISINUS9183851057
Volume160,944.00
Exchange VenueNAS

Company Profile

vTv Therapeutics Inc is a biopharmaceutical company engaged in drug discovery and development. Its therapies are intended to treat diseases such as Alzheimer's and type-II diabetes. Its other products include TTP399, type II diabetes drug candidate.

Key Information
Price/Earning-
Price/Book0.00
Price/Sales54.00
P/CF-
Rev Growth (3 year avg)63.36
EPS Growth (3 year avg)-
Operating Margin % -755.86
Net Margin %-471.92
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 24/04/2020
Annual Report
en 31/12/2019

Financials

Income Statement
USD201420152016201720182019
Revenue (m)1.550.520.630.2912.432.76
Operating Income (m)-28.90-38.14-55.02-50.68-19.82-20.89
Net Income (m)-36.10-27.50-16.35-16.14-7.91-13.04
Basic EPS-1.10-3.32-1.71-1.67-0.69-0.59
Avg. Diluted Shares Outstanding (m)32.818.289.559.6912.4530.29
Balance Sheet
USD201420152016201720182019
Current Assets (m)1.6189.1952.1220.363.472.84
Non Current Assets (m)11.342.352.387.565.096.43
Total Assets (m)12.9591.5354.5027.928.569.27
Current Liabilities (m)6.867.7311.4326.9318.8413.38
Total Liabilities (m)------
Total Equity (m)-498.81-77.97-90.95-151.05-82.85-49.02
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-30.78-36.95-48.21-44.56-26.86-23.02
Capital Expenditure (m)-0.03-0.10-0.09-0.06-0.01-0.07
Figures are quoted in USD unless stated otherwise
0.05 (1.77%)
$
2.87
Last Price